FTC v Edwards: Medical Devices

Case Study

Aug 20, 2025

∙ Paid

In August 2025, the Federal Trade Commission (FTC) submitted a complaint to prevent Edwards Lifesciences Corp. (Edwards) from acquiring JenaValve Technology, Inc. (Jena) because of concerns regarding the market for transcatheter aortic valve replacement (TAVR) devices for aortic regurgitation (AR).

Continue reading this post for free, courtesy of econworks.

Or purchase a paid subscription.